Insider filing · AORT
John E Davis
Chief Commercial Officer
profile →
Artivion, Inc.
AORT · Healthcare · 59 filings in 24 months
ticker →
John E Davis sold $472K of Artivion (AORT)
Executed Aug 12 2025, disclosed Aug 14 2025, 2 days later.
Value, as filed
$472K
10,802 sh × $43.67
Executed
Aug 12 2025
the trade date, as filed
Disclosed
Aug 14 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JDJohn E Davis (Chief Commercial Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Artivion, Inc. (AORT). The largest single filing was $574K of AORT (12,787 sh across 2 lots, as filed), executed Nov 14 2025.
The name
AORTHealthcare · Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by John E Davis in AORT
AORTSALE
Artivion, Inc.
$173K4,573 sh × $37.78
Exec Mar 3
Filed Mar 4 · 5:30 PM ET AORTSALE Artivion, Inc. $106K
2,784 sh × $38.02
Exec Mar 2
Filed Mar 3 · 5:30 PM ET AORTSALE Artivion, Inc. $142K
3,773 sh × $37.59
Exec Feb 23
Filed Feb 25 · 5:30 PM ET AORTSALE Artivion, Inc. $226K
5,000 sh × $45.11
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $574K
12,787 sh across 2 lots
Exec Nov 14 2025
Filed Nov 18 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $301K
6,563 sh × $45.86
Exec Nov 13 2025
Filed Nov 14 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $151K
3,373 sh × $44.62
Exec Nov 10 2025
Filed Nov 12 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $357K
15,100 sh × $23.61
Exec Mar 11 2025
Filed Mar 12 2025 · 5:30 PM ET